Issue: April 2020

Read more

April 20, 2020
1 min read
Save

MAVERICK-HCM

Issue: April 2020

Assessment of safety and exploratory efficacy endpoints with once-daily mavacamten (MyoKardia) vs. placebo.

COBRA-BPS